Oncology PracticeNeoadjuvant combo yields high pathologic response in NSCLCSeptember 25, 2018Lung Cancer
Oncology PracticeCGP guides cancer patient management, facilitates trial enrollmentSeptember 24, 2018Lung CancerPatient & Survivor Care
Oncology PracticeFirst combo trial of mTOR/BRAF inhibition shows potentialSeptember 23, 2018MelanomaLung CancerCNS/Brain CancerGastroenterologyHead & Neck/Thyroid CancersGastrointestinal Cancer
Oncology PracticePD-1/PD-L1 treatment linked to hyperprogressive disease in lung cancer patientsSeptember 20, 2018Immuno-oncologyLung Cancer
Oncology PracticeFatal toxicities from checkpoint inhibitors vary by agentSeptember 19, 2018Immuno-oncologyMelanomaLung Cancer
Oncology PracticeESMO scale offers guidance on cancer targetsSeptember 6, 2018Lung CancerBreast CancerPatient & Survivor CareMelanomaGastroenterologyGastrointestinal Cancer
Oncology PracticePD1 mRNA may predict response to anti-PD1 monotherapy across cancer typesSeptember 4, 2018Immuno-oncologyMelanomaLung CancerRenal Cell Carcinoma
Oncology PracticeCapmatinib plus gefitinib overcomes EGFR resistance in NSCLCAugust 29, 2018Lung Cancer
Oncology PracticeAdding checkpoint inhibitors to radiotherapy requires particular caution in this one scenarioAugust 24, 2018Immuno-oncologyLung CancerCNS/Brain CancerMelanoma
Oncology PracticeMore frequent CT surveillance in NSCLC doesn’t improve survivalAugust 24, 2018Lung Cancer
Oncology PracticeBaseline steroids may reduce efficacy of checkpoint inhibitorsAugust 24, 2018Lung CancerImmuno-oncology
Oncology PracticeFDA grants full approval to pembrolizumab for advanced NSCLCAugust 20, 2018Lung Cancer
Oncology PracticeFDA grants accelerated approval for Opdivo in metastatic SCLCAugust 20, 2018Lung Cancer
Oncology PracticeAggressive drainage regimen may promote spontaneous pleurodesisAugust 15, 2018Lung Cancer
Oncology PracticeLow-dose CT fails to improve small cell lung cancer survivalAugust 14, 2018Lung Cancer
